Armistice Capital Master Fund Ltd.
CIK 1633584 · last filed 2022-02-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$90.80M
Companies
12
Total Filings
74
Lifetime Open-Market Net
-$1.01B
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVTX | Director | 16,393 | $18.82 | $308.5K | $335.4K | 1 | 2022-02-28 |
| Avalo Therapeutics, Inc. (CERC) Delisted | Director | 39,712,442 | $2.93 | $116.36M | $24.90M | 19 | 2021-08-18 |
| EYEG | Director | 2,576,500 | $34.75 | $89.54M | -$39.51M | 5 | 2021-08-03 |
| AYTU | Director | 134,238 | $2.18 | $292.6K | -$121.50M | 8 | 2021-05-10 |
| TENX | Director | 2,449 | $15.72 | $38.5K | $369.7K | 1 | 2020-09-03 |
| Vaxart, Inc. (VXRT) Delisted | Director | 14,970,909 | $0.32 | $4.79M | -$898.30M | 5 | 2020-06-30 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | 10%+ Owner | 4,400,000 | — | — | $2.60M | 1 | 2020-01-28 |
| ACHV | 10%+ Owner | 95,599 | $6.50 | $621.4K | -$2.37M | 1 | 2019-06-13 |
| Del Frisco's Restaurant Group, Inc. (DFRG) Delisted | 10%+ Owner | 6,000,000 | — | — | $12.02M | 4 | 2019-04-30 |
| Valeritas Holdings Inc. (VLRX) Delisted | 10%+ Owner | 1,972,500 | — | — | $845.8K | 3 | 2018-12-20 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | 10%+ Owner | 35,025,915 | — | — | $3.38M | 13 | 2018-10-09 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | 10%+ Owner | 1,222,757 | — | — | $7.58M | 4 | 2018-07-02 |
Recent Filings · Page 3 of 8
74 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-19 | AYTU | Other (J) | +1,005,837 | $0 | EDGAR |
| 2020-01-28 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Buy (P) | +270,000 | $2.60M | EDGAR |
| 2020-01-24 | Avalo Therapeutics, Inc. (CERC) Delisted | Conv (C) | +24,000,000 | $0 | EDGAR |
| 2019-12-23 | — | Buy (P) | +36,144 | $186.5K | |
| 2019-12-18 | — | Buy (P) | +9,000 | $47.2K | |
| 2019-12-06 | — | Buy (P) | +5,787 | $30.0K | |
| 2019-11-13 | — | Buy (P) | +1,201,908 | $61.8K | |
| 2019-11-01 | AYTU | Conv (C) | +8,253,444 | $7.26M | EDGAR |
| 2019-10-16 | AYTU | Buy (P) | — | $0 | EDGAR |
| 2019-10-07 | Vaxart, Inc. (VXRT) Delisted | Buy (P) | +1,692,000 | $609.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.